DigestRedComo funciona
Red
/
Empresas
Di
No verificado

Dispatch Bio

Sobre qué escribimos

BiotecnologíaCienciaIndustriaOncologíaSalud

7 Comunicados de prensa

Ver todos los comunicados de prensa
12/01/2026
Multimedia
Telefonía
Industria
Biotecnología
Salud
Ciencia
Oncología
Dispatch Bio and CARsgen Announce Clinical Collaboration to Evaluate Flare Platform and Zevor-cel in Solid Tumors
Fuente
Dispatch Bio
Editor
Business Wire
1.00
0
12/01/2026
Industria
Ciencia
Biotecnología
Oncología
Salud
Higiene alimentaria
Medicina - Varios
Dispatch Bio Announces FDA Clearance of IND Application for DISP-10, a First-in-Class Immunotherapy Treatment, in Solid Tumors
Fuente
Dispatch Bio
Editor
Business Wire
1.00
0
04/11/2025
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Eventos
Mercado laboral
Dispatch Bio Unveils First Clinical Program and Presents Data Supporting Flare Platform at Society for Immunotherapy of Cancer (SITC) 2025 Annual Meeting
Fuente
Dispatch Bio
Editor
Business Wire
1.00
0
04/11/2025
Mercado laboral
Eventos
Industria
Oncología
Salud
Medicina - Varios
Ciencia
Biotecnología
Dispatch Bio Announces Clinical Supply and Collaboration Agreement with Bristol Myers Squibb in Solid Tumors
Fuente
Dispatch Bio
Editor
Business Wire
1.00
0
03/10/2025
Biotecnología
Salud
Oncología
Eventos
Industria
Dispatch Bio Announces Upcoming Presentations at Society for Immunotherapy of Cancer (SITC) 2025 Annual Meeting
Fuente
Dispatch Bio
Editor
Business Wire
1.00
0
30/09/2025
Oncología
Salud
Ciencia
Medicina - Varios
Biotecnología
Mercado laboral
Dispatch Bio Appoints Mauro Avanzi, M.D., Ph.D., as Chief Medical Officer
Fuente
Dispatch Bio
Editor
Business Wire
1.00
0
23/07/2025
Oncología
Salud
Ciencia
Biotecnología
Industria
Dispatch Bio Launches to Deliver Universal Treatment Across Solid Tumors with Novel Immunotherapy Approach
Fuente
Dispatch Bio
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0